Timo Paavonen
Papers
1
Total Citations
87
H-Index
1
About
Dr. Timo Paavonen is a pioneering researcher in the field of medical diagnostics, with a primary focus on the application of electronic nose (eNose) technology for noninvasive cancer detection. His most notable contribution is the landmark 2014 proof-of-principle study, "Detection of Prostate Cancer by an Electronic Nose," which demonstrated that the ChemPro® 100-eNose could accurately discriminate prostate cancer from benign prostatic hyperplasia by analyzing volatile organic compounds in urine headspace. This work, cited 87 times, established a clinically viable, rapid, and noninvasive diagnostic approach that could reduce unnecessary biopsies. Paavonen’s research bridges analytical chemistry and urological oncology, offering a paradigm shift in early cancer screening. His impact is underscored by the study’s role as a foundational reference for subsequent eNose-based diagnostics, inspiring further investigations into breath and urine analysis for various malignancies. By translating sensor technology into a practical clinical tool, Paavonen has advanced the frontier of point-of-care diagnostics, making him a key figure in the evolution of noninvasive cancer detection.
Research Focus
Key Achievements
Top Papers
- 1